Psychotherapy — talk therapy with a professional to help a person manage their emotional state and mental health — can…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
The U.S. Food and Drug Administration (FDA) has granted regenerative medicine advanced therapy (RMAT) status to AMT-130, an experimental…
For people with Huntington’s disease who are struggling to get a good night’s sleep, establishing good sleep hygiene —…
There’s a sore need to provide more psychological support to people living with Huntington’s disease and their families, not…
The outlook for the Huntington’s disease community has never been brighter, with better care options and promising new research…
The U.S. Food and Drug Administration (FDA) has authorized new dosage strengths of Austedo XR (deutetrabenazine) extended-release tablets for…
The 39th annual convention of the Huntington’s Disease Society of America (HDSA) is launching this evening for “three days…
Small molecules developed by Design Therapeutics were able to reduce the activity of the disease-causing mutant gene in…
A first clinical trial of SKY-0515, an experimental treatment for Huntington’s disease, is starting to give multiple ascending doses to…
The Huntington’s Disease Society of America (HDSA) has awarded grants totaling more than $2.1 million to support its…